Related Experiment Video
Updated: Jun 18, 2026

Synthesis of 1,2-Azaborines and the Preparation of Their Protein Complexes with T4 Lysozyme Mutants
Published on: March 25, 2017
Antibody buffering of systemically administered lysozyme
Carol O'Hear1, Jefferson Foote
1Children's Hospital Boston, Boston, MA, USA.
Objective:
To assess the ability of an anti-lysozyme antibody to stabilize the plasma pharmacokinetics of lysozyme through a 'buffering' effect.
Methods:
Hen egg lysozyme was radiolabeled with (14)C and infused with or without the murine anti-lysozyme antibody D1.3 into the jugular vein of rats. The dosages of antibody and lysozyme were varied, and the antibody and lysozyme were administered either together or in separate infusions.
Results:
Buffering of lysozyme with an equimolar amount of D1.3 more than doubled the plasma half-life of lysozyme and addition of more antibody buffer prolonged the half-life to an even greater extent. D1.3 bound lysozyme that was infused several minutes after the D1.3 administration, indicating that D1.3 can be charged with drug in vivo.
Conclusion:
Antibody buffering of monovalent therapeutic enzymes is possible and may have potential for clinical use.
Related Concept Videos
Buffers
Buffer Systems in the Body
A typical buffer system in bodily fluids includes a weak acid and its corresponding anion,...
Protein Buffers in Blood Plasma and Cells
Certain amino acids can exist in a zwitterion state at a...
Humoral Immune Responses
Buffers: Overview
Buffer Effectiveness
The buffer capacity is the amount of acid or base that can be added to a given volume...

